Myopic maculopathy among Chinese children with high myopia and its association with choroidal and retinal changes: the SCALE-HM study
Junjie Deng,Xian Xu,Chen-Wei Pan,Jingjing Wang,Mingguang He,Bo Zhang,Jinliuxing Yang,Xiao-Wen Hou,Zhuoting Zhu,Grace Borchert,Jun Chen,Tianyu Cheng,Suqing Yu,Ying Fan,Kun Liu,Haidong Zou,Xun Xu,Xiangui He
DOI: https://doi.org/10.1136/bjo-2022-321839
2024-05-21
Abstract:Aims: To investigate myopic maculopathy in Chinese children with high myopia and its association with choroidal and retinal changes. Methods: This cross-sectional study included Chinese children aged 4-18 years with high myopia. Myopic maculopathy was classified by fundus photography and retinal thickness (RT) and choroidal thickness (ChT) in the posterior pole were measured by swept-source optical coherence tomography. A receiver operation curve was used to determine the efficacy of fundus factors in classifying myopic maculopathy. Results: In total, 579 children aged 12.8±3.2 years with a mean spherical equivalent of -8.44±2.20 D were included. The proportions of tessellated fundus and diffuse chorioretinal atrophy were 43.52% (N=252) and 8.64% (N=50), respectively. Tessellated fundus was associated with a thinner macular ChT (OR=0.968, 95% CI: 0.961 to 0.975, p<0.001) and RT (OR=0.977, 95% CI: 0.959 to 0.996, p=0.016), longer axial length (OR=1.545, 95% CI: 1.198 to 1.991, p=0.001) and older age (OR=1.134, 95% CI: 1.047 to 1.228, p=0.002) and less associated with male children (OR=0.564, 95% CI: 0.348 to 0.914, p=0.020). Only a thinner macular ChT (OR=0.942, 95% CI: 0.926 to 0.959, p<0.001) was independently associated with diffuse chorioretinal atrophy. When using nasal macular ChT for classifying myopic maculopathy, the optimal cut-off value was 129.00 µm (area under the curve (AUC)=0.801) and 83.85 µm (AUC=0.910) for tessellated fundus and diffuse chorioretinal atrophy, respectively. Conclusion: A large proportion of highly myopic Chinese children suffer from myopic maculopathy. Nasal macular ChT may serve as a useful index for classifying and assessing paediatric myopic maculopathy. Trial registration number: NCT03666052.
What problem does this paper attempt to address?